3
Clinical Trials associated with JWK-002 / RecruitingEarly Phase 1IIT Clinical Study on the Safety and Efficacy of JWK002 Injection Administered as a Single Subretinal Injection in Subjects With X-linked Retinoschisis
This trial is to evaluate the safety and efficacy of JWK002 treatment of X-linked retinoschisis(XLRS). This study will enroll subjects aged 5-18 years old to receive a sub-retinal injection of JWK002.
/ RecruitingNot ApplicableIIT Clinical study on the safety and efficacy of JWK002 injection administered as a single subretinal injection in subjects with X-linked retinoschisis
Start Date16 Oct 2023 |
Sponsor / Collaborator- |
/ Not yet recruitingPhase 1/2 一项在X连锁视网膜劈裂症(XLRS)患者中评价JWK002注射液的安全性、耐受性和初步有效性的I/II期临床研究
[Translation] A Phase I/II clinical study to evaluate the safety, tolerability and preliminary efficacy of JWK002 injection in patients with X-linked retinoschisis (XLRS)
评估JWK002注射液在XLRS患者中单次视网膜下注射给药的安全性和耐受性,获得安全剂量范围
[Translation] To evaluate the safety and tolerability of a single subretinal injection of JWK002 injection in patients with XLRS and to obtain a safe dose range
100 Clinical Results associated with JWK-002
100 Translational Medicine associated with JWK-002
100 Patents (Medical) associated with JWK-002
100 Deals associated with JWK-002